cvs health glp-1 receptor agonists weight management diabetes treatments What is GLP-1? Learning more about the glucagon-like peptide-1 hormone Today, we released promising data

The changing landscape emphasizes the importance of ongoing research, patient education, and smart market strategies to ensure the continued expansion and success of GLP-1 agonists in the dynamic field of diabetes treatments

Among them, GLP-1 and GIP (gastric inhibitory polypeptide) are known as incretins, gut-derived hormones that enhance glucose-dependent insulin secretion, playing a pivotal role in maintaining glucose homeostasis and serve as important therapeutic targets for type 2 diabetes and obesity

Effects of liraglutide compared with placebo on events of acute gallbladder or biliary disease in patients with type 2 diabetes at high risk for cardiovascular events in the LEADER randomized trial

It is not an officially licensed obesity medication in the UK

However, we cannot completely rule out residual confounding

Heres what to know about how weight loss medications work, who theyre best for, potential side effects, and more